Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 7,253 $ 62,937
Restricted cash 34 185
Accounts receivable, net of allowance of $647 and $309 at December 31, 2022 and 2021, respectively 46,565 57,980
Inventory 18,556 17,217
Prepaid expenses and other current assets 17,289 18,833
Total current assets 89,697 157,152
Property, plant and equipment, net 7,351 7,741
Goodwill 13,641 13,641
Intangible assets, net 5,302 6,438
Right-of-use assets, net 5,697 6,585
Other non-current assets 3,407 3,942
Total assets 125,095 195,499
Current liabilities:    
Accounts payable 26,173 29,709
Accrued expenses and other current liabilities 32,243 26,967
Deferred revenue 2,892 2,902
Senior term loan, current portion 40,529 3,187
Subordinated debt 11,119 10,577
Subordinated term loan - related party 41,528
Convertible debt 43,928
Current portion of long-term debt 259 275
Total current liabilities 198,671 73,617
Subordinated term loan - related party 37,991
Senior term loan 37,876
Convertible debt 41,343
Other long-term liabilities 7,223 20,924
Total liabilities 205,894 211,751
Stockholders’ deficit:    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 74,283,026 and 72,335,952 shares issued and outstanding at December 31, 2022 and 2021, respectively 7 7
Additional paid-in capital 770,427 749,592
Accumulated deficit (851,233) (765,851)
Total stockholders’ deficit (80,799) (16,252)
Total liabilities and stockholders’ deficit $ 125,095 $ 195,499